Novel role of PKR in inflammasome activation and HMGB1 release.

Activation and regulation of the inflammasomes. Nat Rev Immunol (2013) 5.71

ER stress-induced cell death mechanisms. Biochim Biophys Acta (2013) 3.07

The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol (2013) 2.22

Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity (2013) 2.02

HMGB1 in health and disease. Mol Aspects Med (2014) 1.67

Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury. Am J Transplant (2013) 1.59

Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol (2013) 1.51

Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice. Diabetes (2013) 1.50

Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab (2013) 1.45

The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis. PLoS One (2015) 1.43

PKR is not obligatory for high-fat diet-induced obesity and its associated metabolic and inflammatory complications. Nat Commun (2016) 1.41

Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology (2013) 1.40

Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death Differ (2013) 1.39

Diversion of stress granules and P-bodies during viral infection. Virology (2013) 1.33

JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci U S A (2014) 1.31

Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells. J Immunol (2013) 1.28

Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol (2016) 1.27

Strange attractors: DAMPs and autophagy link tumor cell death and immunity. Cell Death Dis (2013) 1.25

The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages. Eur J Immunol (2013) 1.21

Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J Cereb Blood Flow Metab (2014) 1.20

Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol (2015) 1.20

New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. Am J Pathol (2013) 1.19

Regulation of HMGB1 release by inflammasomes. Protein Cell (2013) 1.18

Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med (2013) 1.17

An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology. Front Immunol (2013) 1.17

Mapping the crossroads of immune activation and cellular stress response pathways. EMBO J (2013) 1.15

A critical role for PKR complexes with TRBP in Immunometabolic regulation and eIF2α phosphorylation in obesity. Cell Rep (2015) 1.11

TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis. EMBO J (2012) 1.11

Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol (2013) 1.11

PKR-dependent inflammatory signals. Sci Signal (2012) 1.07

Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol (2015) 1.06

3,4-methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome. J Biol Chem (2013) 1.05

Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nat Chem Biol (2013) 1.04

Tumor immunity times out: TIM-3 and HMGB1. Nat Immunol (2012) 1.04

Bacterial RNA:DNA hybrids are activators of the NLRP3 inflammasome. Proc Natl Acad Sci U S A (2014) 1.04

Regulation of stress granules and P-bodies during RNA virus infection. Wiley Interdiscip Rev RNA (2013) 1.03

High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J Biol Chem (2014) 1.03

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells. Nat Genet (2015) 1.02

Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation. Nat Commun (2015) 1.01

Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am J Cancer Res (2013) 1.01

Targeting HMGB1 in the treatment of sepsis. Expert Opin Ther Targets (2014) 0.99

Licensing Adaptive Immunity by NOD-Like Receptors. Front Immunol (2013) 0.99

Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptake. Biochem Pharmacol (2012) 0.98

Role of caspase-1 in regulation of triglyceride metabolism. Proc Natl Acad Sci U S A (2013) 0.97

α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. Mol Med (2014) 0.97

The expanding role of NLRs in antiviral immunity. Immunol Rev (2013) 0.96

Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome. EMBO Rep (2013) 0.96

Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death Differ (2014) 0.96

Adaptive gene amplification as an intermediate step in the expansion of virus host range. PLoS Pathog (2014) 0.95

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. J Virol (2014) 0.95

Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci (2016) 0.95

Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nat Commun (2015) 0.94

Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol (2014) 0.94

Beyond pattern recognition: NOD-like receptors in dendritic cells. Trends Immunol (2013) 0.94

Inflammation, metaflammation and immunometabolic disorders. Nature (2017) 0.93

Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice. Gastroenterology (2015) 0.93

Immunity to viruses: learning from successful human vaccines. Immunol Rev (2013) 0.92

Unsolved Mysteries in NLR Biology. Front Immunol (2013) 0.92

Carbenoxolone blocks endotoxin-induced protein kinase R (PKR) activation and high mobility group box 1 (HMGB1) release. Mol Med (2013) 0.92

Emerging Concepts about NAIP/NLRC4 Inflammasomes. Front Immunol (2014) 0.91

NLRP3 inflammasome and host protection against bacterial infection. J Korean Med Sci (2013) 0.91

NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes. PLoS One (2015) 0.90

Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screening. PLoS One (2013) 0.89

Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease. Mediators Inflamm (2015) 0.89

HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C(high) inflammatory monocytes in murine sepsis survivors. J Intern Med (2013) 0.89

Ménage à Trois in stress: DAMPs, redox and autophagy. Semin Cancer Biol (2013) 0.89

It Is Not Just Folklore: The Aqueous Extract of Mung Bean Coat Is Protective against Sepsis. Evid Based Complement Alternat Med (2012) 0.89

High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule. Mol Med (2015) 0.89

Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder. Front Neurosci (2014) 0.88

Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol Med (2015) 0.88

Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment. J Lipid Res (2016) 0.87

Oxidative stress-mediated HMGB1 biology. Front Physiol (2015) 0.87

Double-stranded RNA-dependent protein kinase deficiency protects the heart from systolic overload-induced congestive heart failure. Circulation (2014) 0.87

Cell death and DAMPs in acute pancreatitis. Mol Med (2014) 0.86

P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation. Int J Mol Med (2015) 0.86

STAT2: A shape-shifting anti-viral super STAT. JAKSTAT (2013) 0.86

The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation. J Biol Chem (2014) 0.86

Targeting inflammasomes in rheumatic diseases. Nat Rev Rheumatol (2013) 0.86

Interferon-induced guanylate-binding proteins in inflammasome activation and host defense. Nat Immunol (2016) 0.84

Sepsis and disseminated intravascular coagulation. J Intensive Care (2016) 0.84

The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med (2014) 0.84

Novel Mechanisms of Herbal Therapies for Inhibiting HMGB1 Secretion or Action. Evid Based Complement Alternat Med (2015) 0.84

Recognition of herpes simplex viruses: toll-like receptors and beyond. J Mol Biol (2013) 0.84

Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3. J Immunol (2014) 0.84

How macrophages ring the inflammation alarm. Proc Natl Acad Sci U S A (2014) 0.84

High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome. Mol Med (2015) 0.84

Involvement of interleukin-1β in the autophagic process of microglia: relevance to Alzheimer's disease. J Neuroinflammation (2013) 0.84

Role of p58IPK in Endoplasmic Reticulum Stress-associated Apoptosis and Inflammation. J Ophthalmic Vis Res (2014) 0.83

HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms. Diagn Pathol (2015) 0.83

Deficient PKR in RAX/PKR Association Ameliorates Ethanol-Induced Neurotoxicity in the Developing Cerebellum. Cerebellum (2015) 0.83

IPAF inflammasome is involved in interleukin-1β production from astrocytes, induced by palmitate; implications for Alzheimer's Disease. Neurobiol Aging (2013) 0.82

Activation of protein kinase PKR requires dimerization-induced cis-phosphorylation within the activation loop. J Biol Chem (2013) 0.82

Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts. Ann Rheum Dis (2012) 0.82

Mechanisms and pathways of innate immune activation and regulation in health and cancer. Hum Vaccin Immunother (2014) 0.82

The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-κB-mediated release of high-mobility group box-1. Am J Respir Cell Mol Biol (2015) 0.82

Caspase-1 activity is required for UVB-induced apoptosis of human keratinocytes. J Invest Dermatol (2015) 0.81

HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. J Neuroinflammation (2015) 0.81

Role of ROS and HMGB1 in contact allergen-induced IL-18 production in human keratinocytes. J Invest Dermatol (2014) 0.81

Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation. Biomed Res Int (2014) 0.81

P2X7 receptor activation regulates rapid unconventional export of transglutaminase-2. J Cell Sci (2015) 0.80

Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43

The inflammasomes. Cell (2010) 19.37

Non-canonical inflammasome activation targets caspase-11. Nature (2011) 8.85

Inflammasomes in health and disease. Nature (2012) 6.75

HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23

Sensing and reacting to microbes through the inflammasomes. Nat Immunol (2012) 5.24

Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. Cell (2005) 4.41

Regulation of inflammasome signaling. Nat Immunol (2012) 4.10

Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell (2010) 4.01

HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature (2009) 3.86

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A (2010) 3.80

The inflammasome: first line of the immune response to cell stress. Cell (2006) 3.73

Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell (2005) 3.38

Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med (2006) 3.26

The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature (2004) 3.18

Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol (2011) 3.05

Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature (2011) 2.93

Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol (2010) 2.88

A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol (2012) 2.59

Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci U S A (2007) 2.48

NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol (2009) 2.39

The PYHIN protein family as mediators of host defenses. Immunol Rev (2011) 1.90

Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol (2011) 1.85

The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J Immunol (2007) 1.46

Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol (2008) 1.32

RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. Blood (2006) 1.24

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science (2004) 19.08

TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49

A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27

Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science (2006) 13.91

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 11.57

Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 9.83

Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell (2008) 7.37

Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol (2011) 6.53

Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med (2004) 6.38

The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity (2009) 6.37

HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med (2011) 6.15

Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (2011) 5.87

Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab (2010) 5.82

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov (2008) 5.78

The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol (2011) 5.73

Sepsis definitions: time for change. Lancet (2013) 5.63

Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature (2011) 4.78

Endogenous HMGB1 regulates autophagy. J Cell Biol (2010) 4.71

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol (2008) 4.60

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature (2007) 4.59

NLRX1 is a regulator of mitochondrial antiviral immunity. Nature (2008) 4.55

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock (2006) 4.53

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med (2010) 4.37

Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology (2011) 4.06

Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell (2010) 4.01

Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med (2009) 3.97

Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res (2007) 3.96

Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell (2008) 3.91

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A (2010) 3.80

Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2003) 3.75

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A (2002) 3.68

Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med (2006) 3.66

Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med (2007) 3.63

Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med (2005) 3.58

Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe (2007) 3.52

Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab (2005) 3.51

Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes (2008) 3.47

Theoretical, empirical and practical approaches to resolving the unmet information needs of clinical information system users. Proc AMIA Symp (2002) 3.45

Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med (2009) 3.43

DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A (2006) 3.41

Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med (2007) 3.27

Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med (2006) 3.26

Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS (2007) 3.18

A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood (2007) 3.09

The cytokine activity of HMGB1. J Leukoc Biol (2005) 3.02

Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci U S A (2006) 3.02

Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med (2005) 3.01

HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology (2002) 2.95

Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab (2011) 2.91

Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev (2008) 2.89

The "cytokine profile": a code for sepsis. Trends Mol Med (2005) 2.89

Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med (2012) 2.89

Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol (2010) 2.88

Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med (2002) 2.83

Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med (2012) 2.79

HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol (2012) 2.75

Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69

microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med (2010) 2.68

Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol (2010) 2.65

A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol (2012) 2.59

Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A (2008) 2.58